Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
INFLAMASE FORTE |
| Manufacturer |
|
Novartis Ophthalmics |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Prednisolone sodium phosphate 1%; oph soln; contains benzalkonium chloride. |
| Indications |
|
Ocular inflammation. |
| Children |
|
Not recommended. |
| Adults |
|
Initially 1–2 drops every hour during day and every 2 hours at night; after response, reduce to 1 drop every 4 hours; then 1 drop 3–4 times daily as needed. |
| Contraindications |
|
Ocular fungal, mycobacterial, viral (except herpes zoster), or untreated bacterial infections. |
| Precautions |
|
Not for use after uncomplicated removal of foreign body. Corneal or scleral thinning. Glaucoma. Monitor IOP and for secondary infections. Avoid abrupt cessation in prolonged use. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Prolonged use: increased IOP, cataracts, corneal perforations, optic nerve damage, delayed wound healing; may mask or worsen infections. |
| How Supplied |
|
Soln—5mL, 10mL, 15mL |
|
|
|
|
